CA1084846A - Zinc salt and anionic polymer to control mouth odor - Google Patents

Zinc salt and anionic polymer to control mouth odor

Info

Publication number
CA1084846A
CA1084846A CA277,803A CA277803A CA1084846A CA 1084846 A CA1084846 A CA 1084846A CA 277803 A CA277803 A CA 277803A CA 1084846 A CA1084846 A CA 1084846A
Authority
CA
Canada
Prior art keywords
zinc
polymer
composition
anionic
same meaning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA277,803A
Other languages
French (fr)
Inventor
Maria C.S. Gaffar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of CA1084846A publication Critical patent/CA1084846A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties
    • A61K2800/542Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5424Polymers characterized by specific structures/properties characterized by the charge anionic

Abstract

Abstract of the Disclosure A novel composition to prevent and control mouth odor, which is also effective in preventing calculus, plaque, caries and periodontal disease containing as the essential agent, a zinc-polymer combination formed by the reaction or interaction of a zinc compound with an anionic polymer containing carboxylic, sulfonic and/or phosphonic acid radicals.

Description

10848~6 This invention relates to novel oral formulations comprising a combination of a zinc compound and an anionic polymer as an effective agent against mouth odor, plaque calculus and periodontal disease.
The prior art is replete with oral compositions con- -taining zinc salts such as zinc chloride, zinc iodide, zinc fluoride, zinc sulfide, zinc phenol sulfonate and the like as antiseptic agents, and correctives of oral conditions such as pyorrhea. Zinc chloride has commonly been used in oral formulations for its astringency propertiesO Zinc phenol sulonate has been utilized in the prior art dentifrice compositions as an anti-plaque and anti-calculus agent as well as an odor inhibitor of fermentation and putrefaction which occurs in the oral eavity. These soluble zinc salts have the dual disadvantage of leaving an unpleasant astringent taste in the mouth as well as having short-lived efficacy against plaque, calculus and as an odor inhibitor.
Sparingly soluble zinc salts such as zinc citrate; zinc ;~
C14-alkyl maleate, zinc benzoate, zinc caproate, zinc carbonate, r ' ..~' zinc citrate, etc. have been used in dentifrice formulations !' to prolon~ the anti-calculus and anti-plaque effectiveness of the zinc ions due to the slow dissolution of the zinc ¦¦salts in the saliva. The sparingly soluble characteristic 'lof these zinc salts promotes longevity of action against plaque and calculus at the expense of initial or immediate efficacy.
The use of a zinc co~plex of a specific diketone as an j agent for cornbating tartar and tooth discoloration is also lo 'known, as set forth in German ~atent No. 2,229,466. Thus, it ! iS apparant that zinc compounds generally are known to have 'deodorizing properties as well as efficacy against plaque, calculus and possibly yeriodontal disease.
I~ Also known is the use of a water soluble sodium salt ,of a linear anionic polymer as an anti-calculus agent, as set ~forth in ~.S. Patent No. 3,429,963 to Shedlovsky. This patent ~discloses that the hydrolyzed copolymers and/or polymers iprevent the deposition of calculus by means of their calcium sequestration properties. However, there is no suggestion in Ijthis patent, nor in any of the known prior art, that a combination of a zinc salt and an anionic polymer is unusually effective in preventing and controlling mouth odor while simultaneously preventing calculus, plaque, caries and peri-~odontal disease.
Accordingly, it is an object of this invention to provide an oral composition containing as the mouth odor inhibitor, the reaction product of a zinc salt with an anionic polymer-Another object of instant invention is to provide an
-2-. _ .. . . _ _ __.. _ , .

484~

oral composition effective in inhibiting mouth odor over a protracted period of time.
Still another object of this invention is to provide an oral com-position effective in inhibiting plaque, calculus, caries and periodontal disease.
It has been found, through radioisotope studies, that anionic polymers can be adsorbed onto oral surfaces. Accordingly, an effective method of controlling mouth odor entails the use of an oral composition comprising a zinc polymer salt or complex formed by combining zinc compounds with anionic polymers. The positively charged zinc ions can react with the poly-meric carboxyl, sulfonic or phosphonic acid groups of the anionic polymers to form zinc-polymer combinations. In the presence of excess acidic groups, the zinc-polymer combinations adsorb onto the oral surfaces such as the teeth and oral mucosa, thereby forming a reservoir of zinc ions capable of being gradually released with time into the oral environment.
According to the present invention, there is provided a non-astringent tasting oral composition capable of countering mouth odor, compris-ing effective amounts of a combination of a zinc compound and an anionic polymer containing carboxylic, sulfonic or phosphonic acid radicals. Said zinc-polymer combinations provide both a means of attachment to the oral cav-ity as well as form a reservoir of zinc ions which are gradually released over a protracted period of ~ime as an effective means to combat mouth odor, pla~ue, calculus, and periodontal disease. In addition, the zinc-polymer combinations decrease the high astringency which is characteristic of zinc ions, thereby leaving a more pleasant taste in the mouthO
It has been ascertained through equilibrium dialysis ...

.. ... .
:
... .

108484~

', , i ' studies against water that the zinc ions are bound tothe ianionic polymer and are slowly released with time as clearly indicated by the results in Table I, wherein 0. 025% zinc oxide llplus 2,',~ of a copolymer of vinyl methyl ether and maleic ~lanhydride having a molecular weight of 250~ 000 (Gantrez 119) I ,!was tested against zinc oxide per se.
1,l ,l Table I
Equilibrium Dial~sis Studies l Rate of Dissociation 10 , _ Coml~ound 10 Min 1 Hr 24 Hrs ~Zn 2 ~ Gantreztll9 * 0 0 53 ,zn+2 ~ H20 21 70 100 . ' ~
Ij j * 0. 025~o zinc oxide + 2~o Gantrez 119 ; pH adjusted to 6~5 with ** 0~ 025~ zinc oxide t lN HCl ; pH adjusted to 6 ~ 5 with 3N NH40H
I
The above table clearly shows that no zinc was detected in the dialysate (ou-tside membrane) after 10 minutes, and after 1 hour of dialysis; and only ~3~o zinc was found in the ', ,Idialysate after 24 hours dialysis. Whereas, in the absence of ,,the polymer, 21~ zinc was detected in the dialysate after ', ' '.only 10 minutes, 70~ zinc was found after only 1 hour and lOO~o .zinc was found in the dialysate after 24 hours dialysis. In '.'the presence of saliva salts, the zinc ions are bound to the ¦

'Ipolymer and are even more gradually released wi~h time, with "only 7~ zinc being detected in the dialysate after 24 AurS.

''t Trademark ., -4-., ~
"

,' ' 10848~6 , In contrast, in the absence of the polymer, thezinc is dialyzed ~out ~% after 10 minutes; 50% after 1 hour; and lOO~o after 24hours.
~l 'l'he anionic polymers are well known in the art. Prefer-ably, the polymer is one which is linear and water-soluble.
For example, it may be soluble in water, when in its sodium or ammonium salt form, at least to i;he extent of the concen- ¦
tration in which it is employed ( O. l~o to lO~o) . See for instance lithe anionic polymeric materials described in U.S. No. 2,984,639, lo 3,325,402, 3,429,963, the article on "Polyelectrolytes" in Vol. 10 of Encyclopedia of Polymer Science pages 781 ff, particularly pages 781, 782 and 784 listing various poly-electrolytes. The anionic polymers employed herein preferably ~ contain ionizable carboxyl, sulfonic or phosphonic groups. A
preferred type of polymers has its ionic substituents on a polymer chain which is hydrocarbon preferably aliphatic ~hydrocarbon (e.g. a vinyl polymer). Typical of such anionic polymers are copolymers of an unsaturated polybasic carboxylic lacid or anhydride thereof (preferably dibasic and having 4 carbon atoms per molecule) and of an olefin having 2 or more carbon atoms per molecule; polyolefin sulfonates; polyolefin phosphonates; and polyolefin phosphates, the olefin group -~
containing 2 or more carbon atoms. Suitable examples include~ !
' 1. A copolymer of maleic anhydride with ethylene, or 25 i styrene, or isobutylene, or polymethyl vinyl ether, or , polyethylvinyl ether, having recurring ~roups:

; ' X ff H---CH
¦! OOM COOM1 ' wherein ~ and r~!1 are individual~y hydrogen, sodium, potassium .~ -5-~, , I
__ ... ._._. ~, 'lor arnrnoniu~n and may be the same or different, and X is ethylene, styrene, isobutylene, methylvinyl ether, and ! ethylvinyl ether.
Il 2. A polyacrylic acid and polyacrylates thereof having 5 It recurring groups: ¦
¦~ _ CH------CH2 IH CH2 ¦I COO~ COOM
,~wherein M and ~1 have the same meaning as above.
Il 3. A polyitaconic acid and polyitaconates thereof 10 llhaving recurring groups: ~' ~H2 ff O~M

{~H2 OOM
, 1 ~'wherein M and ~1 have the same meaning as above.
ll 4. A polyolefin sulfonate having recurring groupss CH - CH
0=~=0 I OM
~,wherein M has the same meaning as above.
5, A polyvinyl phosphonate having recurring groups:
i ii MO-~=o . ' OMl !
~ j 6, A polyvinyl phosphate having recurring groups- i , ,, ~

' MO-P~O
~M 1 , _ . , .

1~3848~6 .
I
~Good results have been obtained with anionic polymers of very high molecular weight such as about 500~000 or 1,O00,000 as well as of relative]y low molecular weights of at least l,OO0 'land preferably 1,500 to 500,000. The anionic polymer consti-~tutes about 0.1 to 10~ by weight and preferably 0~5-1~5yo of the oral composition.
The zinc compounds that form the zinc-polymer combination by reaction or interaction with said anionic polymer may be any physiologically acceptable zinc salt including the water soluble and insoluble, organic and inorganic zinc salts.
Any zinc compound equivalent to 1.5 mFI/ml zinc may be mixed with the anionic polymer. Examples of suitable zinc compounds that may be employed includes ,'~zinc acetate zinc isovalerate 15~ 'zinc acetylacetonate zinc D-lactate zinc ammonium sulfate zinc DL-lactate zinc benzoate zinc laurate i r zinc bromide zinc hexafluorosilicate zinc beryllium orthosilicate zinc methacrylate zinc borate zinc molybdate 'zinc butylphthalate zinc naphthenate zinc butylxanthate zinc octoate ~' zinc caprylate zinc oleate ; zinc carbonate zinc orthophosphate zinc chloroanilate zinc phenolsulfonate ~ zinc chlorate zinc pyridine-2-thiol-1-oxide I zinc chromate zinc pyrophosphate , zinc citrate zinc resinate i zinc cyclohexanebutyrate zinc salicylate ~ -7-' i .

zinc chlori~ zinc sulfate zinc ~allate zinc nitrate zinc fluoride zinc selenide zinc alpha-glucoheptonate zinc stearate zinc gluconate zinc sulfanilate zinc glycerophosphate zinc tartrate zinc hydroxide zinc tellurate zinc ~-hydroxyquinoline zinc tungstate ,zinc 12-hydroxystearate zinc valerate 10 ~!zinc iodide zinc vanadate zinc acrylate zinc tribromosalicylanilide zinc oxide zinc ricinoleate ;zinc propionate '~Although the majority of ~e zinc salts might have limited solubility in water, the presence of the anionic polymer does increase the solubility of the combinction. Zinc oxide or zinc ~propionate, for example, are insoluble in water but in the presence of adequate amounts of the anionic polymer they are Ijsolubilized. The pH thereof can be adjusted to ~.5 to 7.0 `with dilute NH40H and the clarity of the solutions are retained.

~,any insoluble zinc salts are rendered soluble when combined with the anionic polymers, thereby providing a means of following the interaction or reaction between zinc and the anionic polymer. The zinc compound constitutes about .01-5%
~5 and preferably .025-1~ by weight of the oral composition.
The solubility of the zinc-polymer combination appears to be a factor in the activity against odor formation. Soluble conlbinations of anionic polymer and zinc salt aEe very effective in inhibiting odor formation, whereas insoluble zinc-!~olymer combinations are less effective in reducing odor Ii i , . _ formation. Soluble combinations of the anionic polymer withzinc oxide, or zinc propionate are very effective in inhibiting VSC (volatile sulfur compoun~),whereas the insoluble zinc-polymer combinations such as polymer ~ zinc pyrophosphate, zinc ~lycerophosphate, or zinc, 8-OH quinoline were ineffective or only slightly effective.
Another factor which influences the efficacy of the zinc-poly~er comb~ion as an odor-inhibitor is the counterion in the original zinc compound. The zinc gluconate, and zinc alpha-glucoheptonate polymer combinations are soluble but substantially inactive in reducin~ mouth odor. The zinc salicylate-~olymer combinations are possibly effective a~ainst , ..
periodontal disease because of the anti-inflammatory properties of the salicylate counterion in addition to the benefit from ' 15 the zinc ions of the suppression of mouth odor. I
Aqueous solutions and dispersions of various zinc compounds were tested in an in vitro system co~sting of whole ,human saliva, L-cysteine as substrate, and incubated for 3 , hours at 37C in an airtight container. After incubation, ~ithe headspace VSC (volatile sulfur compoun~)formation was ,,measured by an instrumental GC-flame photometric technique.
Since mouth odor has been attributed to the presence of ` volatile sulfur compounds such as hydrogen sulfide, methyl mercaptan and dimethyl sulfide resulting from putrefactive processes occuring in the oral cavity, aforesaid in vitro test provide results comparable to in vivo sensory evaluations.
The results, as set forth in ~able II, show excellent VSC
inhibition for the zinc oxide, zinc chloride and zinc propionate combinations with the anionic polymer. Zinc chloride plus water was used as the control compound.

!

.
.

~084846 Table II

Com~ound *~O VSC Inhibition Zinc oxide + G-1191 (soluble) 52 ¦

;IZinc chloride + G-119 (soluble) 36 5 IZinc propionate + G-ll9 (soluble) 53 Zinc gluconate + G-119 (soluble) f 15 IlZinc alpha-glucoheptonate + G-119 (soluble) 15 : Zinc pyrophosphate (insoluble) f 12 .Zinc glycerophosphate + G-ll9 (slightly soluble) 13 lo iZinc 8-OH quinoline + G-119 (slightly soluble) 24 ,l Zinc salicylate + G-119 (soluble) - 17 .
~ Zinc chloride + H20 54 . I
' ' ', ~ Zinc equivalent to 1.6 mg/ml: G-ll~ - 0.1%; pH between 6.5 to !~ 7 ~ ~
- 15 , 1 G-ll9 is the anionic polymer defined in Table I
`. f indicative of promotion of odor formation as opposed to : inhibition .

In addition to the efficacy of the zinc-polymer combina-tions as a mouth odor inhibitor, the taste thereof is distinctly ;different from, and an improvement over, that of zinc chloride as evidenced by a testing program wherein a panel of five persons tasted two samples, via a mouthrinse, containing , _, _ .

equivalent concentrations of zinc ions; one sample containing t Izinc chloride/poly~er combination and the other containing zinc chloride/water plus 0.2% flavor(both at a pH between 5.5-5.~). The participants agreed, without exception, that 5 the two samples were distinctly different and that the zinc 'Ichloride-polymer sample had very little of the astringent, jmetallic taste characteristic of zinc ions. These results show that the presence of the polymer improves the taste f ! ;i zinc-containing solutions by eliminating the astringent taste lO jland the numbing of the tongue attributable to the zinc ions.
~Thus, it is apparent that the zinc-polymer combinations are ;particularly useful in formulations where the taste of zinc creates a disadvantage.
Aqueous dispersions or solutions of zinc-polymer com-15 bination may be produced by adding a zinc salt in the form of ~a dilute solution, a paste or in the dry state, to a dilute solution of anionic polymer, and stopping the addition before the amount of zinc salt is such as to form a precipitate or gel. With good agitation and careful addition not to exceed 20 the amount of maximum solubility of the zinc-polymer complex, a clear solution or dispersion is obtained. This phenonema 'is clearly indicated in Example 2. The anionic polymer solution is preferable adjusted to a pH of about 5,5 with ~iammonium hydroxide or other suitable base prior to the addition 25 of the zinc salt. The pH of the final zinc polymer salt solution is about 4.5-6.o. For example, a suitable zinc polymer salt or complex is formed by adding 0.050M of a zinc salt to 500 ml of a 2~o solution of a copolymer of methylvinyl ether and maleic anhydride, (adjusted to a pH of 5,5 with 3N
30 ammonium hydroxide) and mixing well. The final solution or ., I
. . .

' 1084846 , '.
! disZpersi.on of the zine-anionic polymer complex preferably has a pH of abou-t 4.5-6.o. lt is believed th~t the ionized ~carboxyl groups react or interact with the zinc ion to form a zinc-polymer salt or complex. See the article by Crisp et lal, J Dent Res March-April 1976, ~, 2, pp.299-308, particularly l,pp.305-307: and by Begala et al, The Journal of Physical ZChemistry (1972), 76, 2, pp.25Z4-260 dealing with counterion ,Ibin~ing by polycarboxylates. The experimental evidence shows that the bindinZg of zinc to polymers is mostly ionic. Ionic 10 lbindinZg leads to either:
;, I a) chain bridging salts~ , Z
CH2 H20 H20, CH2 CH-COO- ~ CZllOC -CH Z
: CH2 H20 H20 ~ H2 15 b) intra chain salts~ ' , , 1.
, ,i 1 1, ~
! CH2 CH -COO H~O H20 ZZ
CH2 2n 2_ H20 f I !
;, CH-COO- H20 !
c) pendant half salts-Z
Cl H2 H20 H20 CH-COO-Zn -OH `
`' I / i !- CH2 H2 H20 ., Z

. . -- .
.. . .
= ., . . ~ .

d) chelate (ri~ structure with copolymers of vinylmethyl ether and maleic anhydride, since divalent cat~ons like zinc form a chelate with the ether oxygen and one carboxyl group~
j I ! , !
` I 0 - /+2- Jq ~
CH-~0 -2n 0-C-CH -or- IH C00 ~ n+~ H20 CH-0 ~ ~ 0-CH CH 0 / ¦ H~0 I; I I \ I I I ! \ ' 2'CH3 H20 C~ IH2 CH2 CH3 H20 i Accordingly, it is believed that the zinc-polymer complex iæ
ionically bound, but -the exact type of binding (which may also . lo exist as a mixture of above structures) has not been ascertained. !
.
~ ~ The following examples are given to illustrate this , ~ , invention further. In this application all proportions are by weight unless otherwise indicated, Exam~le 1 0.2gm zinechloride is dissolved in 15 ml water and ,added to a 4Y0 aqueous solution of the copolymer of maleic anhydride and methylvinyl ether with agitation and subsequently diluted to 200ml. A clear solution of the zinc-polymer complex , !
is obtained.
ExamPle 2 a) lOOg of an aqueous zinc oxide paste containing 0.5 zinc is prepared and added slowly with continuous stirring to 25 ml of a 1% aqueous solution of methylvinyl ether-maleic ilanhydride copolymer and subsequently diluted with 75 ml water.
iI The final solution has a pH of 5.5 and is slightly cloudy, The ratio of zinc to anionic polymer is 1~2.
b) 100 gm of an aqueous zinc oxide paste containing 0.25%

.l -13-l.

! l i ,, ~
A ,. . , _ ", _., ~, , - 10848~6 ; zinc is added to lOOgm of an aqueous solution containing 0.25%' methylvinyl ether-ma]eic anhydride copolymer with continuous agitation. The final solution has a pH of 6.~ a~ i8 turbid.
The ratio of zinc to anionic polymer is lt 1.
c) A final ~olution of zinc-polymer complex is prepared as above containin~ 0~25~o zinc and 1.0% anionic polymer, a ratio of 1:4, which has a pH of 3.5 and is clear, With the addition of about lOml. 3N ammonium hydroxide to said clear , solution, the pH is adjusted to 6.8 (pH in the oral cavity) and the solution retains its clarity.
This example clearly shows that the ratio of zinc salt to anionic polymer is dependant on the solubility of the i~
final zinc-polymer complex formed, maximum solubility being evidenced by a clear solution which is preferable although I ~
a slight cloudiness is also acceptable. I -ExamPle ~ j A zinc-polymer complex is prepared by mixing 50ml. of 0.05M aqueous solutions of the following zinc salts with 50ml of a 2% aqueuous solution of methylvinyl ether-maleic anhydride copolymer and the pH is adjusted to 5-6 with ammonium hydroxide. The ratio of zinc to polymer is ls 4.
a. zinc oxide which contains 80~34~o zinc and is water insoluble.
b. zinc chloride which contains 47~97/~o zinc and is water soluble.
c. zinc glycerophosphate which contains 27~77~o zinc and is soluble in water and insoluble in alcohol, d. zinc salicylate which contains 19.25~o zinc and is soluble in water and alcohol.
e. zinc alpha glucoheptonate which contains 19~7~o zinc and is water soluble.

., i , . . . .
,, . :

.1 ;, .j f. zinc propionate which contains 30.91~ zinc and is only 32~ soluble in water and 28J/o soluble in alcohol.
Ig. zinc salt of 8-hydroxyquinoline which contains 18.48~o zinc and is water insoluble.
l~h. zinc gluconate which contains 25~ zinc and is water soluble.
l¦i. zinc pyrophosphate which contains 42.91% zinc and is - I insoluble in water, but soluble in dilute mineral acids.
~ The final solutions containing the zinc-anionic polymer .~ li ; lcomplex were all clear except for the solutions containing zinc pyrophosphate which was cloudy and turbid, the zinc 8-hydroxyquinoline which was yellow and turbid and the zinc glycerophosphate which was cloudy and slightly turbid. The ` zinc propionate which was initially a cloudy precipitate ~became clear upon the addition of the anionic polymer.
' While particularly good results in terms of odor inhibition and other salutary effects in the oral cavity and on tooth surfaces, have thus far been obtained by applying simply the aqueous solutions or dispersions of the zinc-polymer complex, it will be understood that it is within the broader aspect of the invention to incorporate said complex into oral compositions generally, such as clear or cloudy mouth rinses and transparant or opaque toothpastes, troches, chewing gum, tablet or powder containing a dental vehicle.
; Likewise, the complex may be formed in situ, during the ?
preparation of said oral compositions or even on dilution in ,, the mouth; or the zinc compound and the anionic polymer may imerely act cooperatively within said oral cavity and not form :, ; a detectable complex.

,. -15- ~

, . , ._ ~

108484~;

! The vehicle, often referred to as a dental vehicle contains liquids and solids. In general, the liquid compri8es ` !Iwater and/or a humectant such as glycerine, sorbitol, propylene glycol or polyethylene glycol 400 including suitable mixtures ~Ithereof. It is usually advantageous to use a mixture of both ! water and one or two humectants. The total liquid content is ;; ~
Igenerally about 20-90 percent by weight of the vehicle. In ¦transparent and translucent vehicles, the liquid content of the toothpaste may be about 20-90 percent by weight, while in opaque lo ~vehicles the total liquid content is usually about 20-50 percent~
by weight. The preferred humectants are glycerine and sorbitol.
Typically clear, that is transparent or translucent, vehicle contains 0-80 percent by weight of glycerine, about 20-80 percent by weight of sorbitol and about 20-80 percent by 'Iweight of water. Opaque vehicles typically contain about 15-35 percent by weight of glycerine and about 10-30 percent by weight of water.
The solid portion of-~e vehicle is a gelling agent.
'In the instant invention the gelling agent includes alkali , metal carboxymethyl cellulose in amount of at least about 0.25 percent by weight of the vehicle. Additional gelling agents may also be present. Gelling agents which~ay be addi-tionally present include viscarin, gelatin, starch, glucose, sucrose, polyvinyl pyrollidone, polyvinyl alcohol, gum traga-canth, gum karaya, hydroxy propyl cellulose, methyl cellulose,carboxyethyl cellulose, sodium alginate. Laponite CP or SP, ` which are each synthetic inorganic complex silicate clays sold under trademark by Laporte Industries, Lt~d., and magnesium ,¦ aluminum silicate gel. The solid portion or gelling agent of
3 the vehicle is typically present in amount of about 0.25-lO

,' I
_ __ _ !

~0~4846 percent by weight of the toothpaste and preferably about 0.5-8 percent by weight. Alkali met~l carboxymethyl ~ellulose includes the lithium, sodium and potassium salts.
' Any suitable substantialy water-insoluble polishing 'lagent may be added to the gel vehicle. There i8 a relatively large number of such m~rials known in the art. Representative Imaterials include, for example, dicalcium phosphate, tricalcium ,phosphate, insoluble sodium metaphosphate, aluminum hydroxide, magnesium carbonate, calcium carbonate, calcium pyrophosphate, 'calcium sulfate, bentonite, etc., including suitable mixtures thereof. It is preferred to use the water-insoluble phosphate sodium metaphosphate and/or a calcium phosphate, such as dicalcium phosphate dihydrate. In general, these polishing ;agents will comprise a major proportion by weight of the solid ingredients. The polishing agent content is variable, but will 'generally be up to about 75 percent by weight of the total lcomposition~ generally about 20-75 percent; although, as indicated below, even lower amounts of polishing agent can be employed.
, Any suitable surface-active or detersive material may be iincorporated in the gel vehicle. Such compatible materials are desirable to provide additional detersive, foaming and antibacterial properties dependngupon the specific type of surface-active material and are selected similarly. These deter-!~gents are water-soluble organic compounds usually, and may be lanionic, nonionic, or cationic in structure. It is preferred to use the water-soluble non-soap or synthetic organic detergents usually. Suitable detersive materials are known and include, for example, the water-soluble salts of higher fatty acid mono-Iglyceride monosulfate detergent (e.c., sodium coconut fatty acid monoglyceride monosulfate), higher alkyl sulfates(e.g., sodium 1~ 1 . . ~

`' 10~4846 . I
l lauryl sulfate), alkyl aryl sulfonate (e.g., sodium dodecyl ll benzene sulfonate), higher fatty acid esters of 1,2-dihydroxy-I propane~ulfonate) and the like.
'!
The various surface-active materials may be used in any suitable amount, generally from about 0.05 to about 10 percent il by weight, and preferably from about 0.5 to 5 percent by weight Ij of the dentifrice composition.
It is a further embodiment of the present invention to 1, use the substantially saturated higher aliphatic acyl amides lo ll of lower aliphatic amino carboxylic acid compounds, such as ,I those llaving 12 to 16 carbons in the acyl radical, and as more particularly described in U.S. Patent No, 2,689,170 issued September 14, 1954. The amino acid portion is derived generally , from the lower aliphatic saturated monoamino carboxylic acids 1 having about 2 to 6 carbons, usually the monocarboxylic acid compounds. Suitable compounds are the fatty acid amides of , glycine, sarcosine, alanine, 3-aminopropanoic acid and valine having about 12 to 16 carbo~ in the acyl group. It is preferred Ii to use the N-lauroyl myristoyl and palmitoyl sarcoside compounds, 20 fi however, for optimum effects.
The amide compounds may be employed in the form of the 1, free acid or preferably as the water-soluble salts thereof, ' such as the alkali metal, ammonium, amine and alkylolamine salts. ¦
I! Specific examples thereof are sodium and potassium N-lauroyl, 25 1' myristoyl and palmitoyl sarcosides, ammonium and ethanolamine, N-lauroyl sarcoside, N-lauroyl sarcosine, and sodium N-lauroyl glycine and alanine. For convenience herein, reference to "amino carboxylic acid compound", "sarcoside", and the like refers to such compounds having a free carboxylic group or the water-soluble carboxylate salts.

iO84846 Various other matorials may be incorporated in the vehicles I
of this invention. ~xamt)les thereof are preservatives, silicones, !
chlorophyll compounds, ammoniated materials such as urea, I diammonium phosphate and mixtures thereof, materials which can increase contrast with the particles, such as ¦titanium dioxide and other constituents. These adjuvants are incorporated in the instant compositions in amounts which do not i,substantially adversely affect the properties and characteristics suitably selected and used in proper amount depending upon the , particular type of preparation involved.
~! Antibacterial agents may also be employed in the gelled vehicles of the instant invention. Typical antibacterial agents include:
N1-(4-chlorobenzyl)-N5-(2,4-dichlorobenzyl) biguanide;
15 ;l p-chlorophenyl biguanide;
4-chlorobenzhydryl biguanide;
4-chlorobenzhydrylguanylurea;
N-3-lauroxypropyl-N-p-chlorobenzylbiguanide: !
, 1,6-di-p-chlorophenylbiguanide hexane;

20 ~ 1-(lauryldimethylammonium)-8-(p-chlorobenzyldimethyl-ammonium) octane dichloride;
5,6-dichloro-2-guanidinobenzimidazole;
N1-p-chlorophenyl-N5-laurylbiguanide;
5-amino-1,3-bis(2-ethy~exyl)-3-methylhexahydro pyrimidines " and their non-toxic acid addition salts.
The antibacterial agent, when present, is employed in amounts of about 0.1-5 percent by weight, preferably about '' 0.05-5 percent.
' Any suitable flavoring or sweetening matèrials may be employed in formulating a flavor for the compositions of the ..
. - 1 9 -, i - ~ 1084846 present invention. ~xamples of suitable flavoring constituents ,include the flavoring oils, etc., oils of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, ,cinnamon, lemon and orange, as well as sodium methylsalicylate.
~ISuitable sweetening agents include sucrose, lactose, maltose, rbitol~ sodium cyclamate and saccharine. Suitably, flavor land sweetenin~ agent may together comprise from about 0,01 to 5 ,percent or more of the compositions of the instant invention.
~ A fluorine-containing compound having a beneficial effect llon the care and hygiene of the oral cavity, e.g., diminution of lenamel solubility in acid and protection of the teeth against decay may also be incorporated in the gelled vehicle. Exam~es thereof include sodium fluoride, stannous fluoride, potassium j'fluoride, potassium stannous fluoride (SnF2-KF), sodium hexa-,fluorostannate, stannous chlorofluoride, sodium fluorozirconate,~and sodium monofluorophosphate. These materials, which dis-associate or release fluorine-containing ions in water, suitably ~'may be present in an effective but non-toxic amount, usually ! ~ .
within the range of about 0.01 to 1 percent by weight of the water-soluble fluorine content thereof.
The oral preparation may also be a liquid such as mouth rinse which typically contains 20-99% by weight of an aqueous ~i ~lower aliphatic alcohol, preferably h~ving about 1-30% by weight alcohol such as ethanol, n-propyl, or isopropyl alcohol.

'' ~
,. I
Such oral preparations are typically applied by brushing the teeth or rinsing the oral cavity for 30-90 seconds at least once daily. Typical oral preparations of the invention which "

!
.

... . . ...

:, 1084846 ~can be applied in this manner are set forth below.

" ~xample 4 Preparation of Zinc-Polymer Mouthrinse ! Total volume = 1 liter 5 tlSolution A On mixing with B
(Mouthrinse concentra~e) ~ (gms/100 ml) Final conc:

Ethyl alcohol------ 20 10 Pluronic~F-108*---- 8 4 1 Flavor------------- 0.4 0.2 10 ~' ' Glycerin----------- 20 10 Saccharin---------- O. o6 o . o3 ll 0.1~ FD & C Color-- o.6 0.3 Deionized water q.s. 100.0 * A polyalkene oxide block polymer ,Solution B
(Zinc-Polymer Complex) A 2~ polymer solution is prepared by adding methyl vinyl etherl-maleic anhydride copolymer (Gantrez) to 500 ml of water (pre-heated ~to 90C) with continuous stirring until a clear solution is ob-"tained. The polymer solution is cooled to room temperature and the '`pH is adjusted to 5.5 with addition of 3N ammonium hydroxide. Thenl ,,0.05 M of zinc oxide salt is added with stirring. The mixture is a, ,clear solution.
, 500 ml of solution A is added to 500 ml of solution B with ~continuous stirring (e.g. magnetic stirrer). The pH Or the mixture~
is between 4 and 6, and is a clear mouth rinse. The final concen-ttration of zinc salt in the mouthrinse is 0.025 M and of polymer is 1~.
, Equilibrium dialysis studies showed that the zinc-polymer complex in a typical mouth rinse formulation retains its identity in the presence of saliva salts and ex~ibits a slow !

, t Trademark .
,; _ '` I

rate of dissociation. After 10 minutes, 3% dissociation was I! noted; after 1 hour, 5% dissociation occured; and after 24 hours, 12% ~issociation was measured. The slow release of the j zinc ions and the increased retention of the zinc in the oral cavity enhance the effectiveness of instant oral compositions ~containing the zinc-polymer complex against mouth odor, plaque, jgingivitis and other oral disorders.

Example 5 Mouthwash o ~1 %
Ethyl alcohol 15.0 Non-ionic detergent (Pluronic F-108)1 4.0 I Flavor Q.2 i~ I
15 !i Glycerin 10.0 Saccharin -3 j FD~C color (0.1%) 0-3 J' Anionic polymer (Gantrez~119)2 1.0 1~ Zinc chloride 0. 025 20 !i Water q.s. lOOml.
1 A polyalkene oxide block polymer J, i 2 Copolymer of maleic anhydride and methylvinyl ether having a malecular weight of 250~ 000~
' The zinc chloride powder is added to a 2~o aqueous solution ,f the anionic polymer and stirred until dissolved and the pH
"is adjusted to 5 ~ 5 with ammonium hydroxide and then the mouth rinse concentrate containing the remaining ingredients is added to the zinc-polymer solution in accordance with the procedure of xam ~) l e ~ -t Trademark ;

__ . . .. . _ ._ ..... . ~ ., _,, In vitro VSC Inhibition tests on thi~ mouthrinse in the presence of saliva gave the following resultsl ., I
! Table IlI
C Inhibition ~ Sample inc~bha~Son incu~at~
5 'I zinc chloride mouthrinse 72 50 zinc chloride-polymer rinse 72 80 'rhese results clearly show the long range effectiveness of the zinc-polymer complex as a mouth odor inhibitor.
.
. Example 6 .
Dental Cream ,1 ~o '~ Anionic polymer of Example 1 1.0 " Zinc chloride 0.025 ,~ Nonionic detergent* 1.00 ~.
15 ,! Glycerine 22.00 Sodium pyrophosphate 0.25 Car~oxymethyl cellulose 0.85 Sodium saccharin 0.20 1, Sodium benzoate 0.50 20 ' Calcium carbonate (precipitated) 5.00 Dicalcium phosphate dihydrate 46.75 ~`lavor 0.80 Water q.s.
. *Tweent80-Polyoxyethylene (20 moles ethylene oxide) sorbitan ' monooleate-t Trademark , !

,~ . . . .

,, ~ . .. ~ P

i 1084846 :
The zinc-polymer complex is prepared in accordance with ¦ the procedure of ~xample 4. The remaining ingredients are ,`admixed with agitation to form a base paste, which is then ~,mixed with the zinc-polymer complex, using either equal 5 ,volumes or weights of the base pasteana the preformed zinc- ¦
~ polymer complex.
jl An effective amount, e.g., about . 01-5~o zinc compound ~land 0.1 to lO~o anionic polymer may also be incorporated in an I inert carrier or dissolved in a suitable vehicle in the formu- ¦
lo ¦'lation of chewing gums and lozenges. Similarly, the zinc-~polymer complex may also be incorporated into a mouth spray.
A typical lozenge formula contains the following ingedients, in ~¦
percent by weight, based on the weight of the total formulation~ ¦
i 75~o to 98~o Sugar i' 5 l l~o to 20% Corn Syrup .1~ to l~o Flavor oil 0% to .03~0 Colorant(s) i .1% to 5~o Tableting Lubricant 1, .2% to 2% Water 20 ll .1% to lO~o Anionic polymer .01v~o to 5% Zn compound Sugarless pressed candy may also be formulated to include the complex ~ this invention. For products of this type, which ,'usually contain powdered sorbitol instead of sugar, synthetic ' sweeteners are mixed with the powdered sorbitol and flavor(s), i colorant(s) and a tablet lubricant are then added. The formula 'lis introduced into a tablet machine to shape the final product. I
A typical sugarless pressed candy contains the~following jl~ingredients~ in percent byweight, based on the weight of the , -24-. i '' 10848~16 ;'tota~. formulation: ' 98% to 99~ 5;Yo Sorbitol ,, .1% to . 9,~'o Flavor(s) 1~ o~r to . 02,~o Synthetic Sweeteners 5 ll oylO to .03% Colorant(s) . 055b to l~/o Tableting Lubricant ,l Obviously many variations of the above described procedures . may, be used to prepare pre~sed candies.
~ A typical chewing gum may contain the following ingredients, !
~! in percent by weight based on the weight of the total gum formu- j ,~ lation:
_n~redients Wei~ht Percent ', , Gum Base From about loYo to about 40% ~1 .l, Sucrose From about 50yo to about 75~o ~5 Corn Syrup or Glucose From about lO;~o to about 205~o Flavor Material From about 0.4~ to about 5%
, Anionic polymer From about .1% to about lO~Yo Zn compound F~om about ~Ol:~o to about 5%
~., An alternate chewing gum formulation is as followss 20 i, ~ Wei~ht Percent Gum Base From about lOY~o to about 50%
Binder From about 3C,~70 to about 10%
. ~
Filler (Sorbito~ Mannitolt ll or combinations thereof) From about 55% to about 80%
25 li Artificial Sweetener and, ! Flavor From about 0.1% to about 5~o ,! Anionic Polymer From about .15S to about 105~o '' Zn compound From about . 0150 to about 5~0 , In certain sugarless gums, there is used as thebinder ingredient 3 1l a solution of sorbitol in water containing from about 10% to , about ~0~, preferably frorn about 50'l~o to about 75yO by weight of t Trademark 1 10848g,~ 1 .
, I'sorbitol in H20. In others, there is used a gum acacia-in-¦'water system containing from about 30% to about 60~o~ preferablyfrom about 45~ to about 50~ by weight of gum acacia powder.
Il The above chewing gum formulations are exemplary only.
IlMany additional formulations are described in the prior art, and in carrying out this invention, such formulations can be ~employed. It is also pos~ble to prepare an acceptable chewing gum product containing a gum base, flavoring material and Zn-l~polymer complex according to the teaching of this invention.
1~ The ingredient referred to heretofore in the formulationssimply as "gum base" is susceptible to many variations. ln `general, a gum base is prepared by heating and blending various ingredients, such as natural gums, synthetic resins, waxes, plastici~ers, etc. in a manner well known in the art. Typical ; 15 , examples of the ingredients found in a chewing gum base are masticatory substances of vegetable origin, such as chicle, ; crown gum, nispero, rosidinha, jelutong, pendare, perillo, jniger gutta, tunu, etc.s masticatory substances of synthetic ~iorigin such as butadiene-styrene polymer, isobutylene-isoprene ~ copolymer, paraffin, petroleum wax, polyethylene, polyiso-'~butylene, polyvinylacetate, etc.; plasticizers such as lanolin,stearic acid, sodium stearate, potassium stearate, etc.
A preferred ingredient of instant composition is a non-ionic organic surfactant which provides increased prophylactic¦
laction, assists in achieving thorough and complete dispersion of instant compositions throughout the oral cavity and renders instant compositions more cosmetically acceptable. The non-ionic surfactant imparts to the composition de~ersive and foam-in~ properties, as well as maintains the flavoring materials 3 in solution (i.e., solubilizes flavor oils). In addition, the . , . , ~.

: - - -.. .

,Inon-ionics are completely compatible with the zinc-anionic ,',complex of this invention, thereby providing for a stable, lZ
,Ihomogeneous composition of superior mouth odor control.
The non-ionic organic surface active compounds which 5 11 are contemplated are commercially kno~n and comprise water-! soluble products which are derived from the condensation of an alkylene oxide or equivalent reactant and a reactive-hydrogen hydrophobe. The hydrophobic organic compounds may be aliphatic, llaromatic or heterocyclic, although the first two classes are lo ¦Zlpreferred. The preferred types of hydrophobes are higher Z
l aliphatic alcohols and alkyl phenols, although others may be - used such as carboxylic acids, carboxamides, sulphonamides, etc. The ethylene oxide condensates with ~,higher-alkyl phenols represent a preferred class of non-ionic 15 icompounds. Usually the hydrophobic moiety should contain at Z
`lleast about 6 carbon atoms, and preferably at least about 8 ! carbon atoms, and may contain as many as about 50 carbon atoms or more. The amount of alkylene oxide will vary considerably, ~depending upon the hydrophobe, but as a general guide and rule, 20 at least about 5 moles of alkylene oxide per mole of hydrophobe should be used. The upper limit of alkylene oxide will vary also, but no particular criticality can be ascribed thereto IAs much as 200 or more moles of alkylene oxide per mole of jhydrophobe may be employed. While ethylene oxide is the pre-25 ~ferred and predominating oxyalkylating reagent, other lower alkylene oxides such as propylene oxide, butylene oxide, and the like, may also be used or substituted in part for the ethylene oxide. Other non-ionic compounds whicn are suitable are the polyoxyalkylene ester~ of the organic acids such as ~ 3 i the higher fatty acids, the rosin acids, tall oil acids, acids ., '', ., , ~ ~Z
.,. i.

,ifrom petroleum oxidation products, etc. These esters will usually contain from about lO to about 22 carbon atoms in the lacid moiety and from about 12 to about 30 moles of ethylene 'oxide or its equivalent.
l~ Still other non-ionic surfactants are the alkylene oxide ~Icondensates with the higher fatty acid amides. The fatty acid 'Igroup will generally contain from about ~ to about 22 carbon ¦atoms and this will be condensed with about lO to about 50 I moles of ethylene oxide as the preferred illustration. The llcorrespondin~r carboxamides and sulphonamides may also be used as substantia1 equivalents.
S-till another class of non-ionic products are the oxyalky- ¦
lated higher aliphatic alcohols. The fatty alcohols should contain at least 6 carbon atoms, and preferably at least about l8 carbon atoms- The most preferred alcohols are lauryl, myri-styl, cetyl, stearyl and oleyl alcohols and the acid alcohols should be condensed with at least about 6 moles of ethylene oxide, and preferably about lO to 30 moles of ethylene oxide..

,A typical non-ionic product is oleyl alcohol condensed with 15 moles of ethylene oxide.
,' i The amount of non-ionic may generally be varied.from about 0 2-3 0~o by weight of the total formulation, depending 'lon the specific nature of the non-ionic utilized, as well as lon the amounts and nature of the oth~ringredients in the oral ¦ .-iformulation.
Although this invention has been described with referenceto specific examples, it will be apparent to one skilled in the art that various modifications may be made thereto which fall within its scope.

; _ _ ._ . , , ,.. ,, . . ... _ , . .. . _~,,

Claims (5)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:

1. A non-astringent tasting oral composition to control mouth odor con-taining as the essential agent, a zinc-polymer complex having a pH of about 4.5 to 6 and comprising about 0.01 to 5% by weight of the composition of a zinc compound and about 0.1 to 10% by weight of the composition of an anionic poly-mer wherein said polymer is anionic, linear and contains ionizable carboxyl, sulfonic or phosphonic groups selected from the group consisting of
1. a copolymer of maleic anhydride with ethylene, or styrene, or isobutylene, or polymethyl vinyl ether, or polyethylvinyl ether, having recurring groups:

wherein M and M1 are individually hydrogen, sodium, potassium or ammonium and may be the same or different, and X is ethylene, styrene, isobutylene, methyl-vinyl ether, and ethylvinyl ether, 2. a polyacrylic acid and polyacrylates thereof having recurring groups:

wherein M and M1 have the same meaning as above, 3. a polyitaconic acid and polyitaconates thereof having recurring groups:

wherein M and M1 have the same meaning as above, 4. a polyolefin sulfonate having recurring groups:

wherein M has the same meaning as above, 5. a polyvinyl phosphonate having recurring groups:

wherein M and M1 have the same meaning as above, 6. and a polyvinyl phosphate having recurring groups:

wherein M and M1 have the same meaning as above, and is ionically bound to a physiologically acceptable zinc salt selected from the group consisting of zinc alpha-glucoheptonate zinc stearate zinc gluconate zinc sulfanilate zinc glycerophosphate zinc tartrate zinc hydroxide zinc tellurate zinc 8-hydroxyquinoline zinc tungstate zinc 12-hydroxystearate zinc valerate zinc iodide zinc vanadate zinc acrylate zinc tribromosalicylanilide zinc oxide zinc ricinoleate zinc propionate, the ratio of zinc salt to anionic polymer being within the range of about 2:1 to 1:4.
2. A composition in accordance with claim 1, wherein said anionic poly-mer is a copolymer of maleic anhydride and methylvinyl ether.
3. A composition in accordance with claim 1, wherein said zinc compound is zinc oxide.
4. A composition in accordance with claim 1, wherein said zinc compound is zinc chloride.
5. A composition in accordance with claim 1, wherein said zinc compound is zinc propionate.
CA277,803A 1976-05-28 1977-05-05 Zinc salt and anionic polymer to control mouth odor Expired CA1084846A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/691,262 US4138477A (en) 1976-05-28 1976-05-28 Composition to control mouth odor
US691,262 1976-05-28

Publications (1)

Publication Number Publication Date
CA1084846A true CA1084846A (en) 1980-09-02

Family

ID=24775812

Family Applications (1)

Application Number Title Priority Date Filing Date
CA277,803A Expired CA1084846A (en) 1976-05-28 1977-05-05 Zinc salt and anionic polymer to control mouth odor

Country Status (2)

Country Link
US (1) US4138477A (en)
CA (1) CA1084846A (en)

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183914A (en) * 1977-12-19 1980-01-15 Abdul Gaffar Magnesium polycarboxylate complexes and anticalculus agents
US4144323A (en) * 1978-06-15 1979-03-13 Lever Brothers Company Novel anticalculus compositions
US4339432A (en) * 1979-06-20 1982-07-13 Lever Brothers Company Oral mouthwash containing zinc and glycine
US4425325A (en) 1979-06-20 1984-01-10 Lever Brothers Company Oral compositions
US4416867A (en) * 1979-06-20 1983-11-22 Lever Brothers Company Oral compositions
US4296096A (en) * 1979-07-05 1981-10-20 Colgate-Palmolive Company High viscosity dentifrice
EP0026252A1 (en) * 1979-09-27 1981-04-08 Blendax-Werke R. Schneider GmbH & Co. Oral hygiene composition
US4362713A (en) * 1980-07-25 1982-12-07 Johnson & Johnson Products Inc. Salts of maleic acid copolymers as dental plaque barrier agents
US4362712A (en) * 1980-07-25 1982-12-07 Johnson & Johnson Products, Inc. Carboxylated naphthalene formaldehyde condensation polymers as dental plaque barriers
US4364924A (en) * 1980-07-25 1982-12-21 Johnson & Johnson Products, Inc. Alkali metal salts of poly(vinylbenzoic acid) as dental plaque barrier agents
AR230182A1 (en) * 1980-07-25 1984-03-01 Johnson & Johnson Prod Inc COMPOSITIONS FOR ORAL HYGIENE CONTAINING SULPHONED POLYMERS OF POLY ARYLENE-ETER-SULPHONE TO PREVENT THE FIXATION OF DENTAL PLATES
US4325939A (en) * 1980-09-22 1982-04-20 Richardson-Vicks Inc. Zinc derivatives and their use in dental compositions
GB2084870B (en) * 1980-10-10 1985-05-09 Muhlemann R Hans Oral compositions containing pyrimidine amine compounds and zinc salts
US4289754A (en) * 1980-11-03 1981-09-15 Richardson-Vicks Inc. Zinc derivatives and their use in mouthwash compositions
US4289755A (en) * 1980-11-03 1981-09-15 Richardson-Vicks Inc. Stable mouthwash compositions containing zinc and fluoride compounds
LU83350A1 (en) * 1981-05-08 1983-03-24 Oreal COMPOSITION FOR THE TREATMENT OF KERATINIC FIBERS BASED ON CATIONIC POLYMER AND ANIONIC POLYMER HAVING VINYLSULFONIC GROUPS AND METHOD OF TREATING THE SAME
US4469674A (en) * 1981-09-03 1984-09-04 Richardson-Vicks Inc. Stable oral compositions containing zinc and fluoride compounds
AU555971B2 (en) * 1981-09-03 1986-10-16 Richardson-Vicks Inc. Stable oral compositions containing zinc and fluoride compounds
US4396599A (en) * 1981-09-17 1983-08-02 Johnson & Johnson Products Inc. Anticaries composition
US4460564A (en) * 1982-11-18 1984-07-17 Johnson & Johnson Products Inc. Anticaries compositions
US4473547A (en) * 1982-11-18 1984-09-25 Johnson & Johnson Products Inc. Anticaries compositions
DE3445695A1 (en) * 1983-12-28 1985-07-11 Colgate-Palmolive Co., New York, N.Y. AGENT FOR ORAL-DENTAL APPLICATION AGAINST PLAQUE AND GINGIVITIS
US4666708A (en) * 1984-01-27 1987-05-19 Oral Research Laboratories, Inc. Dental rinse
US4657758A (en) * 1984-01-27 1987-04-14 Oral Research Laboratories, Inc. Dental rinse
US4568540A (en) * 1984-04-18 1986-02-04 Johnson & Johnson Oral hygiene compositions
US4562066A (en) * 1984-12-11 1985-12-31 Colgate-Palmolive Company Astringent dentifrice containing monofluorophosphate
US4562065A (en) * 1984-12-11 1985-12-31 Colgate-Palmolive Company Astringent dentifrice
US4562063A (en) * 1984-12-11 1985-12-31 Colgate-Palmolive Company Astringent gel dentifrice
US4689214A (en) * 1985-04-16 1987-08-25 Colgate-Palmolive Company Composition to counter breath odor
US4627977A (en) * 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US4921693A (en) * 1985-09-13 1990-05-01 Colgate-Palmolive Company Anticalculus oral composition
US4871531A (en) * 1986-02-10 1989-10-03 Hartlaub Gregory R Oral compositions
US4814163A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant
US4814164A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant composition
US4889712A (en) * 1986-03-20 1989-12-26 Colgate-Palmolive Company Anticalculus oral composition
US4863987A (en) * 1986-04-07 1989-09-05 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Deodorizing coating formulations and deodorizing sheets making use of same
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US5057308A (en) * 1986-11-06 1991-10-15 Hill Ira D Method of treating the oral cavity with oral hygiene preparations containing active SnF2
US5057309A (en) * 1986-11-06 1991-10-15 Hill Ira D Oral hygiene preparations
US5156835A (en) * 1987-01-30 1992-10-20 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5192531A (en) * 1988-12-29 1993-03-09 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5178851A (en) * 1987-01-30 1993-01-12 Colgate-Palmolive Company Antiplaque antibacterial oral composition
US5188821A (en) * 1987-01-30 1993-02-23 Colgate-Palmolive Company Antibacterial antiplaque oral composition mouthwash or liquid dentifrice
GB8724544D0 (en) * 1987-10-20 1987-11-25 Unilever Plc Oral compositions
US4877603A (en) * 1987-12-18 1989-10-31 The Procter & Gamble Company Oral compositions
US4869898A (en) * 1988-01-25 1989-09-26 Colgate-Palmolive Co. Anticalculus oral composition
US4915937A (en) * 1988-08-01 1990-04-10 The Bf Goodrich Company Dental antihydrolysis agent
US5165913A (en) * 1988-11-14 1992-11-24 Ira Hill Controlled release interproximal delivery system
SE507731C2 (en) * 1988-12-29 1998-07-06 Colgate Palmolive Co Antibacterial oral antiplaque composition
ES2023294A6 (en) * 1988-12-29 1992-01-01 Colgate Palmolive Co Oral compositions anti-plate packaged. (Machine-translation by Google Translate, not legally binding)
US4937066A (en) * 1989-06-22 1990-06-26 David G. Vlock Zinc containing oral compositions
US5011830A (en) * 1989-07-03 1991-04-30 The Proctor & Gamble Company Oral compositions having improved anticalculus properties containing pyrophosphate and an acrylic acid polymer
SE512333C2 (en) * 1989-08-25 2000-02-28 Colgate Palmolive Co Antibacterial oral composition with plaque- and tartar-limiting action
US4970065A (en) * 1989-11-15 1990-11-13 Gillette Canada Inc. Stabilized aqueous stannous fluoride mouthwash
US5009883A (en) * 1989-11-15 1991-04-23 Gillette Canada Inc. Aqueous stannous fluoride non-abrasive home treatment gel compositions
US4961924A (en) * 1989-11-15 1990-10-09 Gillette Canada Inc. Stabilized stannous fluoride toothpaste
US5017363A (en) * 1989-11-15 1991-05-21 Gillette Canada, Inc. Stabilized stannous fluoride toothpaste
US4960586A (en) * 1989-11-15 1990-10-02 Gillette Canada Inc. Aqueous stannous fluoride non-abrasive home treatment gel compositions
US5009884A (en) * 1989-11-15 1991-04-23 Gillette Canada Inc. Stabilized aqueous stannous fluoride mouthwash
US4992259A (en) * 1990-01-03 1991-02-12 Johnson & Johnson Consumer Products, Inc. Stable oral composition of zinc
US5011682A (en) * 1990-04-18 1991-04-30 Conopco, Inc. Hypophosphite-containing cotelomers as antitartar agents
US5093170A (en) * 1990-06-25 1992-03-03 The Procter & Gamble Co. Use of a carboxy-substituted polymer to inhibit plaque formation without tooth staining
US5292501A (en) * 1990-06-25 1994-03-08 Degenhardt Charles R Use of a carboxy-substituted polymer to inhibit plaque formation without tooth staining
US5213789A (en) * 1990-08-02 1993-05-25 The Procter & Gamble Company Use of a carboxy-containing copolymer to inhibit plaque formation without tooth staining
US5283924A (en) * 1990-09-21 1994-02-08 Gillette Canada, Inc. Interdental foam brush and treatment gel combination therewith
US5094844A (en) * 1990-12-20 1992-03-10 Colgate-Palmolive Company Anticalculus oral composition
US5211559A (en) * 1991-07-18 1993-05-18 Gillette Canada Inc. Dental treatment tray for holding medicament gel
US5286479A (en) * 1991-12-10 1994-02-15 The Dow Chemical Company Oral compositions for suppressing mouth odors
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5270031A (en) * 1991-12-20 1993-12-14 Block Drug Company Inc. Dentinal desensitizing compositions
US5320830A (en) * 1992-12-30 1994-06-14 The Procter & Gamble Company Oral compositions
US5320831A (en) * 1992-12-30 1994-06-14 The Procter & Gamble Company Oral compositions
US5405836A (en) * 1993-03-02 1995-04-11 Nabisco, Inc. Pet foods with water-soluble zinc compound coating for controlling malodorous breath
US5330748A (en) * 1993-05-19 1994-07-19 Church & Dwight Co., Inc. Dentifrices containing zinc oxide particles
US5385727A (en) * 1993-05-19 1995-01-31 Church & Dwight Co., Inc. Dentifrices containing zinc oxide particles and sodium bicarbonate
US5369145A (en) * 1993-06-14 1994-11-29 Block Drug Company Denture adhesive
FR2707876B1 (en) * 1993-07-23 1995-09-08 Oreal Cosmetic compositions for maintaining hairstyles with improved fixing power.
US5833952A (en) * 1993-09-16 1998-11-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Oral compositions
US5560905A (en) * 1994-05-13 1996-10-01 The Proctor & Gamble Company Oral compositions
US5578294A (en) * 1994-05-13 1996-11-26 The Procter & Gamble Company Oral compositions
US5525652A (en) * 1994-08-10 1996-06-11 Block Drug Company, Inc. Denture adhesive
US5605675A (en) * 1995-06-06 1997-02-25 Enamelon Inc. Processes and compositions for remineralization and prevention of demineralization of dental enamel
US5849271A (en) * 1995-06-07 1998-12-15 The Procter & Gamble Company Oral compositions
US5603922A (en) * 1995-08-08 1997-02-18 Enamelon Inc. Processes and compositions for the remineralization of teeth
US6036944A (en) * 1995-08-08 2000-03-14 Enamelon, Inc. Processes for the remineralization and mineralization of teeth
US5817296A (en) * 1996-09-27 1998-10-06 Enamelon, Inc. Processes and compositions for the remineralization of teeth
AU4083597A (en) 1996-09-27 1998-04-17 Enamelon, Inc. Improved products and methods for the remineralization and prevention of demineralization of teeth
US6159448A (en) * 1996-09-27 2000-12-12 Enamelon, Inc. Products and methods for the remineralization and prevention of demineralization of teeth
EP0839517A3 (en) 1996-11-01 2003-10-01 Unilever N.V. Dental product
US6713049B1 (en) * 1999-11-12 2004-03-30 The Procter & Gamble Company Oral compositions providing optimal surface conditioning
ES2129344B1 (en) * 1997-01-07 2000-03-01 Univ Barcelona Autonoma REMINERALIZING MATERIAL OF ORGANOMINERAL TISSUES.
US6030605A (en) * 1997-04-03 2000-02-29 Nabisco, Inc. Breath freshening compositions and methods using them
US5958380A (en) * 1997-07-07 1999-09-28 Enamelon, Inc. Chewing gum products and the use thereof for remineralizing subsurface dental lesions and for mineralizing exposed dentinal tubules
WO1999063816A1 (en) * 1998-06-09 1999-12-16 Embro William J Method and composition for the treatment of epidermal irritations and infections
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US6358469B1 (en) * 1998-12-01 2002-03-19 S. C. Johnson & Son, Inc. Odor eliminating aqueous formulation
US20040146466A1 (en) 1999-11-12 2004-07-29 The Procter & Gamble Company Method of protecting teeth against erosion
US10470985B2 (en) 1999-11-12 2019-11-12 The Procter & Gamble Company Method of protecting teeth against erosion
US6677391B1 (en) 1999-12-08 2004-01-13 The Procter & Gamble Company Tartar control denture adhesive compositions
US6905672B2 (en) * 1999-12-08 2005-06-14 The Procter & Gamble Company Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants
US6475498B1 (en) * 1999-12-08 2002-11-05 The Procter & Gamble Company Method to inhibit tartar and stain using denture adhesive compositions
US6475497B1 (en) * 1999-12-08 2002-11-05 The Procter & Gamble Company Tartar control denture adhesive compositions
JP2003516329A (en) * 1999-12-08 2003-05-13 ザ、プロクター、エンド、ギャンブル、カンパニー Denture adhesive composition for controlling tartar
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
RU2259193C2 (en) * 2000-12-05 2005-08-27 Колгейт-Палмолив Компани Zinc-containing agent for teeth cleansing with reduced sharpness
ES2178953B1 (en) * 2000-12-20 2003-09-16 Sl Para El Desarrollo Cientifi DENTIFRIC PRODUCT.
US6682722B2 (en) 2001-09-19 2004-01-27 The Procter & Gamble Company Oral compositions providing enhanced overall cleaning
US20050142077A1 (en) * 2001-12-12 2005-06-30 Jose Zimmer Usa of an antimicrobial glass ceramic for dental care and oral hygiene
DE10225123A1 (en) * 2002-06-06 2003-12-18 Goldschmidt Ag Th Highly concentrated aqueous dispersion containing hydrophilic microfine metal oxide particles and dispersing agents
US20040131560A1 (en) * 2002-10-04 2004-07-08 The Procter & Gamble Company Oral compositions and use thereof
AU2004235732B2 (en) * 2003-04-30 2008-04-03 Zicam, Llc Oral spray to reduce cold symptoms and duration of same
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
US20070092552A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Chewable lozenge cold remedy composition and method for making same
US20050084551A1 (en) 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
WO2005058185A1 (en) * 2003-12-11 2005-06-30 Koninklijke Philips Electronics, N.V. Pumping system for an oral composition
US7641892B2 (en) * 2004-07-29 2010-01-05 Cadburry Adams USA, LLC Tooth whitening compositions and delivery systems therefor
US20060024245A1 (en) * 2004-07-29 2006-02-02 Cadbury Adams, Llc. Tooth whitening compositions and delivery systems therefor
WO2007099398A2 (en) 2005-09-27 2007-09-07 Naturalite Benelux B.V. Methods and compositions for treatment of skin
PT1791791T (en) * 2004-09-27 2019-09-12 Special Water Patents B V Methods and compositions for treatment of water
CN1314384C (en) * 2004-11-22 2007-05-09 南方医科大学 Oral cavity nursing agent
US9242125B2 (en) * 2005-07-21 2016-01-26 Coglate-Palmolive Company Oral composition containing non-aggregated zinc nanoparticles
AU2006275744A1 (en) * 2005-07-28 2007-02-08 Indiana University Research & Technology Corporation Niobium oxide compositions, nanostructures, bioactive forms and uses thereof
US8119162B2 (en) * 2005-11-10 2012-02-21 Colgate-Palmolive Company Particles that disrupt or impede bacterial adhesion, related compositions and methods
US20070149642A1 (en) * 2005-12-28 2007-06-28 Sunstar, Inc. Denture fixative composition
WO2007089894A2 (en) * 2006-01-31 2007-08-09 Indiana University Research & Technology Corporation Materials and methods for manufacturing amorphous tricalcium phosphate and metal oxide alloys of amorphous tricalcium phosphate and methods of using the same
US7897800B2 (en) * 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
JP5038331B2 (en) 2006-02-03 2012-10-03 ジェイアール ケム エルエルシー Anti-aging treatment using copper and zinc composition
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US20070212420A1 (en) * 2006-03-10 2007-09-13 Bausch & Lomb Incorporated Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
ES2326382T3 (en) * 2006-03-22 2009-10-08 The Procter And Gamble Company ORAL COMPOSITIONS OF CINC.
MX2008012908A (en) * 2006-04-07 2008-10-13 Procter & Gamble Oral care regimens and kits.
US20070258916A1 (en) * 2006-04-14 2007-11-08 Oregon Health & Science University Oral compositions for treating tooth hypersensitivity
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8628755B2 (en) * 2007-01-30 2014-01-14 Colgate-Palmolive Company Dentifrice containing zinc ions and polyphosphate ions
US20080267891A1 (en) * 2007-04-30 2008-10-30 Colgate-Palmolive Company Oral Care Composition To Reduce Or Eliminate Dental Sensitivity
US20090186090A1 (en) * 2007-04-30 2009-07-23 Colgate-Palmolive Oral Care Composition to Reduce or Eliminate Dental Sensitivity
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
RU2497496C2 (en) 2008-11-25 2013-11-10 Дзе Проктер Энд Гэмбл Компани Antibacterial oral care compositions containing amorphous quartz
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
CN102387775A (en) 2009-04-01 2012-03-21 高露洁-棕榄公司 Dentifrice compositions and methods for treating and preventing damage to tooth surfaces
US8758729B2 (en) 2009-05-18 2014-06-24 Colgate-Palmolive Company Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
TWI442937B (en) 2009-05-26 2014-07-01 Colgate Palmolive Co Higher loading zinc-containing films
MX339923B (en) * 2009-05-26 2016-06-16 Colgate-Palmolive Company * Dentifrice composition.
TWI396554B (en) 2009-05-26 2013-05-21 Colgate Palmolive Co Oral care formulations that enhance amount of soluble zinc
US20110008271A1 (en) * 2009-07-13 2011-01-13 Jr Chem, Llc Rosacea treatments using polymetal complexes
US9968803B2 (en) 2009-10-29 2018-05-15 Colgate-Palmolive Company Low water stannous fluoride plus zinc citrate dentifrice with improved stability, rheology, and efficacy
TWI499430B (en) 2009-12-17 2015-09-11 Colgate Palmolive Co Anti-erosion toothpaste composition
TWI455728B (en) 2010-01-14 2014-10-11 Colgate Palmolive Co Dentifrice compositions
CN103200994B (en) 2010-01-29 2016-02-10 高露洁-棕榄公司 For the oral care product of sensitive enamel nursing
AU2011235154B2 (en) 2010-04-01 2014-06-05 The Procter & Gamble Company Whole mouth malodor control by a combination of antibacterial and deodorizing agents
MX2012013955A (en) 2010-06-23 2013-01-24 Colgate Palmolive Co Therapeutic oral composition.
AU2011279823A1 (en) 2010-07-19 2013-02-07 The Procter & Gamble Company Compositions comprising derivatives of essential oil compounds and use in personal care products
CN104983593B (en) * 2010-11-04 2018-11-20 高露洁-棕榄公司 Dentifrice composition with reduced astringency
EP2635351A1 (en) 2010-11-04 2013-09-11 Colgate-Palmolive Company Dentifrice composition with reduced astringency
AU2015202694B2 (en) * 2010-11-04 2016-07-07 Colgate-Palmolive Company Dentifrice composition with reduced astringency
CA2815640C (en) * 2010-11-12 2016-06-14 Colgate-Palmolive Company Oral care product and methods of use and manufacture thereof
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US20130344120A1 (en) 2012-06-21 2013-12-26 Douglas Craig Scott Mouth Rinse Emulsions
US10123953B2 (en) 2012-06-21 2018-11-13 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
WO2014071284A2 (en) 2012-11-05 2014-05-08 The Procter & Gamble Company Heat treated precipitated silica
WO2014151439A1 (en) * 2013-03-15 2014-09-25 Lubrizol Advanced Materials, Inc. Itaconic acid polymers for oral care applications
JP2016515634A (en) 2013-04-10 2016-05-30 ザ プロクター アンド ギャンブル カンパニー Oral care composition containing polyorganosilsesquioxane particles
JP2016515633A (en) 2013-04-10 2016-05-30 ザ プロクター アンド ギャンブル カンパニー Oral care composition containing polyorganosilsesquioxane particles
BR112015024772A2 (en) 2013-04-10 2017-07-18 Procter & Gamble mouthwash compositions containing polyorganosilesquioxane particles
EP3013309B1 (en) * 2013-06-24 2017-12-27 The Procter and Gamble Company A stain-proof oral care composition
CN105530926B (en) 2013-09-13 2019-07-16 3M创新有限公司 Cationic preservative composition
CN105682746B (en) 2013-10-28 2019-07-26 宝洁公司 The method for preparing personal care composition using fine and close rheology modifier
US9790395B2 (en) 2013-12-26 2017-10-17 Itaconix Corporation Soluble aqueous compositions of zinc salts of selected polyitaconic acid polymers
KR20160103055A (en) 2013-12-26 2016-08-31 이타코닉스 코포레이션 Soluble aqueous compositions of selected polyitaconic acid polymers
CA2946273C (en) 2014-04-30 2021-07-06 Colgate-Palmolive Company Oral care composition comprising small diameter silica, zinc citrate, and a bioadhesive polymer
WO2015171836A1 (en) 2014-05-09 2015-11-12 The Procter & Gamble Company Oral compositions containing stannous
WO2015171837A1 (en) 2014-05-09 2015-11-12 The Procter & Gamble Company Oral compositions containing zinc
DE102014209069A1 (en) * 2014-05-14 2015-11-19 Henkel Ag & Co. Kgaa Oral and dental care and cleaning agents for reducing the discoloration of teeth
CN106794121B (en) * 2014-10-15 2020-12-18 高露洁-棕榄公司 Oral care compositions comprising zinc, arginine and serine
EP3017806B1 (en) 2014-11-04 2018-06-06 The Procter and Gamble Company Anti-tatar oral care compositions providing crystallisation prevention
EP3017807B1 (en) 2014-11-04 2019-01-16 The Procter and Gamble Company Anti-tatar oral care compositions providing crystallisation prevention
US9326925B1 (en) 2015-02-26 2016-05-03 Johnson & Johnson Consumer Inc. Compositions comprising combinations of organic acids
BR112017018113B8 (en) 2015-02-26 2022-07-26 Johnson & Johnson Consumer Inc COMPOSITIONS INCLUDING COMBINATIONS OF ORGANIC ACIDS
US9326924B1 (en) 2015-02-26 2016-05-03 Johnson & Johnson Consumer Inc. Compositions comprising combinations of organic acids
TWI693031B (en) 2015-04-30 2020-05-11 瑞士商菲利浦莫里斯製品股份有限公司 Aerosol-generating article comprising a detachable freshener delivery element with high degree of ventilation
KR102566126B1 (en) 2015-04-30 2023-08-11 필립모리스 프로덕츠 에스.에이. Aerosol-generating article comprising a detachable freshener delivery element having a high resistance to draw
JP2015227361A (en) * 2015-07-23 2015-12-17 コルゲート・パーモリブ・カンパニーColgate−Palmolive Company Dentifrice composition with reduced astringency
JP2015227362A (en) * 2015-07-23 2015-12-17 コルゲート・パーモリブ・カンパニーColgate−Palmolive Company Dentifrice composition with reduced astringency
EP3373901B1 (en) 2015-11-13 2019-12-25 The Procter and Gamble Company Dentifrice compositions with improved fluoride uptake
WO2017079953A1 (en) 2015-11-13 2017-05-18 The Procter & Gamble Company Dentifrice compositions with improved fluoride stability
MX2018005915A (en) 2015-11-13 2019-04-04 Procter & Gamble Dentifrice compositions with dual fluoride source with improved fluoride uptake.
WO2017193284A1 (en) * 2016-05-10 2017-11-16 Colgate-Palmolive Company Alginate dentifrice compositions and methods of making thereof
WO2019032811A1 (en) 2017-08-09 2019-02-14 The Procter & Gamble Company Aptamers for consumer product compositions
JP2021500014A (en) 2017-10-19 2021-01-07 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Aerosol generating article with removable freshener segment
US20190175486A1 (en) 2017-12-07 2019-06-13 Johnson & Johnson Consumer Inc. Oral Care Compositions
US20190175487A1 (en) 2017-12-07 2019-06-13 Johnson & Johnson Consumer Inc. Oral Care Compositions
MX2020006254A (en) 2017-12-18 2020-09-07 Gaba Int Holding Gmbh Oral care compositions.
US11172873B2 (en) 2018-05-17 2021-11-16 The Procter & Gamble Company Systems and methods for hair analysis
WO2019222340A1 (en) 2018-05-17 2019-11-21 The Procter & Gamble Company Systems and methods for hair coverage analysis
US11384357B2 (en) 2018-06-29 2022-07-12 The Procter And Gamble Company Aptamers for personal care applications
EP3956451A1 (en) 2019-04-16 2022-02-23 The Procter & Gamble Company Aptamers for odor control applications
WO2020219323A1 (en) 2019-04-26 2020-10-29 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1593485A (en) * 1925-06-29 1926-07-20 Crosnier Georges Eugene Edme Antiseptic product
US3070510A (en) * 1959-11-03 1962-12-25 Procter & Gamble Dentifrice containing resinous cleaning agents
US3429963A (en) * 1964-06-09 1969-02-25 Colgate Palmolive Co Dental preparation containing polymeric polyelectrolyte
US4022880A (en) * 1973-09-26 1977-05-10 Lever Brothers Company Anticalculus composition
US3943267A (en) * 1974-05-17 1976-03-09 Neil J. Randol Method of remineralizing and immunizing tooth enamel for the prevention and control of tooth decay and dental caries
US3956480A (en) * 1974-07-01 1976-05-11 Colgate-Palmolive Company Treatment of teeth

Also Published As

Publication number Publication date
US4138477A (en) 1979-02-06

Similar Documents

Publication Publication Date Title
CA1084846A (en) Zinc salt and anionic polymer to control mouth odor
US4183914A (en) Magnesium polycarboxylate complexes and anticalculus agents
US4041149A (en) Composition and method of controlling and preventing mouth odor
US5000944A (en) Zinc-containing oral products with reduced astringency
US4992259A (en) Stable oral composition of zinc
US4217343A (en) Magnesium polycarboxylate complexes as anticalculus agents
US3956480A (en) Treatment of teeth
US5670138A (en) Mouth-care products
US4217342A (en) Magnesium polycarboxylate complexes as anticalculus agents
US4689214A (en) Composition to counter breath odor
US5064640A (en) Anticariogenic compositions
US3887701A (en) Antibacterial oral compositions containing preservative-antioxidants
EP3386467A1 (en) Oral care compositions and methods of using the compositions
ZA200601290B (en) Non-aqueous liquid tooth whitening composition
TW200934480A (en) Novel salts and their uses
JPS62252714A (en) Tartar preventive, oral deodorant solid composition
JPS5846012A (en) Stable oral composition containing zinc and fluoride compound
US4863722A (en) Dentifrice compositions
JP2000154127A (en) Composition for oral cavity
EP1158955B1 (en) Compositions containing stannous fluoride for the treatment of hypersensitive teeth
US5587147A (en) Aqueous zinc-polyamide complex solution
JPH09295924A (en) Acid neutralizing agent for dental plaque and composition for oral cavity
CA2286059A1 (en) Dual component dentifrice for fluoridating teeth
AU598324B2 (en) Anticariogenic compositions
EP0242977B1 (en) Oral hygiene compositions

Legal Events

Date Code Title Description
MKEX Expiry